Evaluation of early retinal changes in patients on long-term hydroxychloroquine using optical coherence tomography

Huanhuan Zhao1,2, Menglu Pan1, Yaping Liu3,4

  • 1Department of Rheumatology, First Affiliated Hospital of Anhui Medical University, Hefei, China.

PubMed

Insights

Long-term hydroxychloroquine (HCQ) use in connective tissue diseases (CTD) correlates with retinal vascular changes, detectable by OCTA. However, HCQ concentrations in blood did not show a direct association with these OCTA-measured retinal changes.

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Pharmacology

Background:

  • Connective tissue diseases (CTD), such as lupus and rheumatoid arthritis, are often treated with hydroxychloroquine (HCQ).
  • Prolonged HCQ use can lead to adverse effects, notably retinopathy, necessitating monitoring for early detection of retinal changes.

Purpose of the Study:

  • To identify early retinal alterations using optical coherence tomography angiography (OCTA) in CTD patients undergoing long-term HCQ treatment.
  • To investigate the correlation between OCTA parameters and serum concentrations of HCQ and its metabolites.

Main Methods:

  • A cross-sectional study involved 43 CTD patients treated with HCQ for over 6 months.
  • OCTA was used to measure foveal avascular zone (FAZ) dimensions, macular thickness, and vascular density in the superficial (SCP) and deep (DCP) capillary plexuses.
  • Serum concentrations of HCQ and its metabolites were quantified using high-performance liquid chromatography-tandem mass spectrometry.

Main Results:

  • Cumulative HCQ duration and dose positively correlated with increased FAZ area and perimeter, and negatively with foveal vessel density in both SCP and DCP.
  • No significant correlation was found between OCTA findings and patient age, disease duration, or weight-adjusted HCQ dose.
  • OCTA outcomes did not correlate with measured blood concentrations of HCQ or its metabolites.

Conclusions:

  • OCTA is a valuable tool for detecting microvascular changes in the macula of CTD patients on long-term HCQ therapy.
  • Current findings suggest that serum concentrations of HCQ and its metabolites are not directly associated with the observed retinal vascular changes.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...